 | • レポートコード：D005-13165 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換えヒトエンドスタチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。組換えヒトエンドスタチンの種類別市場規模（純度95％、その他）、用途別市場規模（医療、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、ELISA ・地域別グローバル市場分析 2015年-2020年 ・組換えヒトエンドスタチンの北米市場（アメリカ、カナダ、メキシコ） ・組換えヒトエンドスタチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換えヒトエンドスタチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換えヒトエンドスタチンの南米市場（ブラジル、アルゼンチン） ・組換えヒトエンドスタチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：純度95％、その他 ・用途別分析：医療、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Recombinant Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Recombinant Human Endostatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Recombinant Human Endostatin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Human Endostatin market has been segmented into
Purity:95%
Others
By Application, Recombinant Human Endostatin has been segmented into:
Medical Care
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Human Endostatin market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Human Endostatin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Human Endostatin market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Human Endostatin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Human Endostatin Market Share Analysis
Recombinant Human Endostatin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Human Endostatin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Human Endostatin sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Human Endostatin are:
Thermo Fisher Scientific
ELISA
Among other players domestic and global, Recombinant Human Endostatin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Endostatin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Human Endostatin, with price, sales, revenue and global market share of Recombinant Human Endostatin in 2018 and 2019.
Chapter 3, the Recombinant Human Endostatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Endostatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Recombinant Human Endostatin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Recombinant Human Endostatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Human Endostatin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Endostatin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Purity:95%
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Endostatin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Recombinant Human Endostatin Market
1.4.1 Global Recombinant Human Endostatin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ELISA
2.2.1 ELISA Details
2.2.2 ELISA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ELISA SWOT Analysis
2.2.4 ELISA Product and Services
2.2.5 ELISA Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Recombinant Human Endostatin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Recombinant Human Endostatin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Human Endostatin Manufacturer Market Share in 2019
3.3.2 Top 6 Recombinant Human Endostatin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Recombinant Human Endostatin Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Human Endostatin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Recombinant Human Endostatin Revenue and Market Share by Regions (2015-2020)
4.2 North America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.3 Europe Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.5 South America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Recombinant Human Endostatin Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
5.1.2 North America Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
5.2 United States Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5.3 Canada Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
5.4 Mexico Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Recombinant Human Endostatin Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
6.2 Germany Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.3 UK Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.4 France Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.5 Russia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
6.6 Italy Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Recombinant Human Endostatin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Recombinant Human Endostatin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Recombinant Human Endostatin Revenue and Market Share by Regions (2015-2020)
7.2 China Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.3 Japan Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.4 Korea Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.5 India Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
7.7 Australia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Recombinant Human Endostatin Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
8.1.2 South America Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
8.3 Argentina Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Recombinant Human Endostatin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Recombinant Human Endostatin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Recombinant Human Endostatin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.3 Turkey Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.4 Egypt Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
9.5 South Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Recombinant Human Endostatin Sales and Market Share by Type (2015-2020)
10.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2015-2020)
10.3 Global Recombinant Human Endostatin Price by Type (2015-2020)
11 Global Recombinant Human Endostatin Market Segment by Application
11.1 Global Recombinant Human Endostatin Sales Market Share by Application (2015-2020)
11.2 Global Recombinant Human Endostatin Revenue Market Share by Application (2015-2020)
11.3 Global Recombinant Human Endostatin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Recombinant Human Endostatin Sales, Revenue and Growth Rate (2021-2025)
12.2 Recombinant Human Endostatin Market Forecast by Regions (2021-2025)
12.2.1 North America Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.2 Europe Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.4 South America Recombinant Human Endostatin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Recombinant Human Endostatin Market Forecast (2021-2025)
12.3 Recombinant Human Endostatin Market Forecast by Type (2021-2025)
12.3.1 Global Recombinant Human Endostatin Sales Forecast by Type (2021-2025)
12.3.2 Global Recombinant Human Endostatin Market Share Forecast by Type (2021-2025)
12.4 Recombinant Human Endostatin Market Forecast by Application (2021-2025)
12.4.1 Global Recombinant Human Endostatin Sales Forecast by Application (2021-2025)
12.4.2 Global Recombinant Human Endostatin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Recombinant Human Endostatin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Human Endostatin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Human Endostatin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Thermo Fisher Scientific Recombinant Human Endostatin Major Business
Table 9. Thermo Fisher Scientific Recombinant Human Endostatin Total Revenue (USD Million) (2018-2019)
Table 10. Thermo Fisher Scientific SWOT Analysis
Table 11. Thermo Fisher Scientific Recombinant Human Endostatin Product and Services
Table 12. Thermo Fisher Scientific Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ELISA Basic Information, Manufacturing Base and Competitors
Table 14. ELISA Recombinant Human Endostatin Major Business
Table 15. ELISA Recombinant Human Endostatin Total Revenue (USD Million) (2018-2019)
Table 16. ELISA SWOT Analysis
Table 17. ELISA Recombinant Human Endostatin Product and Services
Table 18. ELISA Recombinant Human Endostatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Recombinant Human Endostatin Sales by Manufacturer (2018-2019) (MT)
Table 20. Global Recombinant Human Endostatin Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Recombinant Human Endostatin Sales by Regions (2015-2020) (MT)
Table 22. Global Recombinant Human Endostatin Sales Market Share by Regions (2015-2020)
Table 23. Global Recombinant Human Endostatin Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 25. North America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 26. North America Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 28. Europe Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 29. Europe Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 30. Europe Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Recombinant Human Endostatin Sales by Regions (2015-2020) (MT)
Table 32. Asia-Pacific Recombinant Human Endostatin Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Recombinant Human Endostatin Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 35. South America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 36. South America Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Recombinant Human Endostatin Sales by Countries (2015-2020) (MT)
Table 39. Middle East & Africa Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Recombinant Human Endostatin Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Table 42. Global Recombinant Human Endostatin Sales by Type (2015-2020) (MT)
Table 43. Global Recombinant Human Endostatin Sales Share by Type (2015-2020)
Table 44. Global Recombinant Human Endostatin Revenue by Type (2015-2020) (USD Million)
Table 45. Global Recombinant Human Endostatin Revenue Share by Type (2015-2020)
Table 46. Global Recombinant Human Endostatin Sales by Application (2015-2020) (MT)
Table 47. Global Recombinant Human Endostatin Sales Share by Application (2015-2020)
Table 48. Global Recombinant Human Endostatin Sales Forecast by Regions (2021-2025) (MT)
Table 49. Global Recombinant Human Endostatin Market Share Forecast by Regions (2021-2025)
Table 50. Global Recombinant Human Endostatin Sales Forecast by Type (2021-2025) (MT)
Table 51. Global Recombinant Human Endostatin Market Share Forecast by Type (2021-2025)
Table 52. Global Recombinant Human Endostatin Sales Forecast by Application (2021-2025)
Table 53. Global Recombinant Human Endostatin Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Recombinant Human Endostatin Picture
Figure 2. Global Sales Market Share of Recombinant Human Endostatin by Type in 2019
Figure 3. Purity:95% Picture
Figure 4. Others Picture
Figure 5. Recombinant Human Endostatin Sales Market Share by Application in 2018
Figure 6. Medical Care Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Recombinant Human Endostatin Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Recombinant Human Endostatin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Recombinant Human Endostatin Sales Market Share by Manufacturer in 2019
Figure 30. Global Recombinant Human Endostatin Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Recombinant Human Endostatin Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Recombinant Human Endostatin Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Recombinant Human Endostatin Revenue Market Share by Regions (2015-2020)
Figure 37. Global Recombinant Human Endostatin Revenue Market Share by Regions in 2018
Figure 38. North America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 39. Europe Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 41. South America Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020)
Figure 43. North America Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Recombinant Human Endostatin Sales Market Share by Countries (2015-2020)
Figure 45. North America Recombinant Human Endostatin Sales Market Share by Countries in 2018
Figure 46. North America Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Recombinant Human Endostatin Revenue Market Share by Countries in 2018
Figure 48. United States Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 54. Germany Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Recombinant Human Endostatin Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Recombinant Human Endostatin Revenue Market Share by Regions 2019
Figure 62. China Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Recombinant Human Endostatin Sales Market Share by Countries in 2019
Figure 69. South America Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 70. Brazil Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Recombinant Human Endostatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Recombinant Human Endostatin Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Recombinant Human Endostatin Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Recombinant Human Endostatin Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Recombinant Human Endostatin Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Recombinant Human Endostatin Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Recombinant Human Endostatin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Recombinant Human Endostatin Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
ヒトエンドスタチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Endostatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Endostatin market repo…- 治療用組換えタンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Therapeutic Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant T…
- 組換えワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 935.1 million by 2025, from USD 822.7 million in 2019. The Recombinant Vacci…
- 組換えグリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant …
- 組み換え非グリコシル化タンパク質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Non-glycosylated Protein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombin…